Dynatronics Corporation (DYNT)
USD 0.13
(10.23%)
USD 0.13
(10.23%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 6.68 Million USD | 18.4% |
| 2023 | 5.64 Million USD | 47.15% |
| 2022 | 3.83 Million USD | -24.51% |
| 2021 | 5.08 Million USD | 401.94% |
| 2020 | 1.01 Million USD | -89.91% |
| 2019 | 10.04 Million USD | 0.91% |
| 2018 | 9.95 Million USD | 64.04% |
| 2017 | 6.06 Million USD | 46.01% |
| 2016 | 4.15 Million USD | -34.26% |
| 2015 | 6.32 Million USD | 24.47% |
| 2014 | 5.07 Million USD | -5.61% |
| 2013 | 5.38 Million USD | -7.37% |
| 2012 | 5.8 Million USD | 11.92% |
| 2011 | 5.19 Million USD | -9.81% |
| 2010 | 5.75 Million USD | -26.29% |
| 2009 | 7.8 Million USD | -14.78% |
| 2008 | 9.16 Million USD | 142.78% |
| 2007 | 3.77 Million USD | 32.17% |
| 2006 | 2.85 Million USD | 57.21% |
| 2005 | 1.81 Million USD | -46.03% |
| 2004 | 3.36 Million USD | 0.92% |
| 2003 | 3.33 Million USD | -7.67% |
| 2002 | 3.61 Million USD | -26.97% |
| 2001 | 4.94 Million USD | 17.5% |
| 2000 | 4.2 Million USD | -20.59% |
| 1999 | 5.3 Million USD | 26.19% |
| 1998 | 4.2 Million USD | 50.0% |
| 1997 | 2.8 Million USD | -6.67% |
| 1996 | 3 Million USD | 36.36% |
| 1995 | 2.2 Million USD | -8.33% |
| 1994 | 2.4 Million USD | 84.62% |
| 1993 | 1.3 Million USD | 1200.0% |
| 1992 | 100 Thousand USD | 0.0% |
| 1991 | - USD | 0.0% |
| 1990 | - USD | 0.0% |
| 1989 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q4 | 6.68 Million USD | -4.69% |
| 2024 Q1 | 1.8 Million USD | -68.06% |
| 2024 Q3 | 7.01 Million USD | 1.57% |
| 2024 Q2 | 6.9 Million USD | 282.94% |
| 2023 FY | 5.64 Million USD | 47.15% |
| 2023 Q1 | 3.51 Million USD | -8.46% |
| 2023 Q4 | 5.64 Million USD | -4.79% |
| 2023 Q3 | 5.93 Million USD | 9.34% |
| 2023 Q2 | 5.42 Million USD | 54.4% |
| 2022 Q1 | 4.77 Million USD | -6.0% |
| 2022 Q3 | 4.15 Million USD | -7.04% |
| 2022 Q2 | 4.47 Million USD | -6.47% |
| 2022 FY | 3.83 Million USD | -24.51% |
| 2022 Q4 | 3.83 Million USD | -7.63% |
| 2021 Q2 | 9.18 Million USD | -3.72% |
| 2021 FY | 5.08 Million USD | 401.94% |
| 2021 Q1 | 9.53 Million USD | 841.39% |
| 2021 Q3 | 8.87 Million USD | -3.39% |
| 2021 Q4 | 5.08 Million USD | -42.68% |
| 2020 Q2 | 11.4 Million USD | -4.98% |
| 2020 Q1 | 11.99 Million USD | 19.47% |
| 2020 Q3 | 12.57 Million USD | 10.3% |
| 2020 Q4 | 1.01 Million USD | -91.94% |
| 2020 FY | 1.01 Million USD | -89.91% |
| 2019 Q3 | 8.4 Million USD | -2.42% |
| 2019 Q4 | 10.04 Million USD | 19.43% |
| 2019 FY | 10.04 Million USD | 0.91% |
| 2019 Q1 | 8.59 Million USD | -13.61% |
| 2019 Q2 | 8.61 Million USD | 0.23% |
| 2018 Q4 | 9.95 Million USD | -2.3% |
| 2018 FY | 9.95 Million USD | 64.04% |
| 2018 Q1 | 10.91 Million USD | 79.92% |
| 2018 Q3 | 10.18 Million USD | -2.75% |
| 2018 Q2 | 10.47 Million USD | -4.04% |
| 2017 Q4 | 6.06 Million USD | -6.89% |
| 2017 FY | 6.06 Million USD | 46.01% |
| 2017 Q1 | 4.05 Million USD | -2.33% |
| 2017 Q2 | 3.98 Million USD | -1.92% |
| 2017 Q3 | 6.51 Million USD | 63.7% |
| 2016 Q4 | 4.15 Million USD | -1.83% |
| 2016 FY | 4.15 Million USD | -34.26% |
| 2016 Q3 | 4.23 Million USD | -15.33% |
| 2016 Q2 | 4.99 Million USD | -1.14% |
| 2016 Q1 | 5.05 Million USD | -20.0% |
| 2015 Q3 | 6.39 Million USD | 4.87% |
| 2015 Q1 | 5.81 Million USD | 14.5% |
| 2015 Q2 | 6.1 Million USD | 4.94% |
| 2015 FY | 6.32 Million USD | 24.47% |
| 2015 Q4 | 6.32 Million USD | -1.22% |
| 2014 Q1 | 5.41 Million USD | 0.68% |
| 2014 Q4 | 5.07 Million USD | -4.37% |
| 2014 Q2 | 5.39 Million USD | -0.39% |
| 2014 Q3 | 5.31 Million USD | -1.59% |
| 2014 FY | 5.07 Million USD | -5.61% |
| 2013 Q2 | 5.8 Million USD | -1.39% |
| 2013 Q4 | 5.38 Million USD | -7.83% |
| 2013 Q3 | 5.83 Million USD | 0.55% |
| 2013 FY | 5.38 Million USD | -7.37% |
| 2013 Q1 | 5.88 Million USD | 1.36% |
| 2012 Q1 | 5.73 Million USD | 10.45% |
| 2012 Q3 | 6.13 Million USD | 13.13% |
| 2012 FY | 5.8 Million USD | 11.92% |
| 2012 Q4 | 5.8 Million USD | -5.32% |
| 2012 Q2 | 5.42 Million USD | -5.41% |
| 2011 FY | 5.19 Million USD | -9.81% |
| 2011 Q4 | 5.19 Million USD | -3.15% |
| 2011 Q3 | 5.35 Million USD | 3.14% |
| 2011 Q2 | 5.19 Million USD | -6.88% |
| 2011 Q1 | 5.58 Million USD | -3.04% |
| 2010 Q1 | 8.15 Million USD | 4.44% |
| 2010 FY | 5.75 Million USD | -26.29% |
| 2010 Q4 | 5.75 Million USD | -17.39% |
| 2010 Q3 | 6.96 Million USD | -5.88% |
| 2010 Q2 | 7.4 Million USD | -9.23% |
| 2009 FY | 7.8 Million USD | -14.78% |
| 2009 Q1 | 8.91 Million USD | -2.72% |
| 2009 Q4 | 7.8 Million USD | -11.47% |
| 2009 Q2 | 9.4 Million USD | 5.57% |
| 2009 Q3 | 8.81 Million USD | -6.27% |
| 2008 Q2 | 9.1 Million USD | 23.75% |
| 2008 Q3 | 9.13 Million USD | 0.27% |
| 2008 FY | 9.16 Million USD | 142.78% |
| 2008 Q4 | 9.16 Million USD | 0.31% |
| 2008 Q1 | 7.36 Million USD | 95.07% |
| 2007 Q1 | 3.08 Million USD | 8.13% |
| 2007 FY | 3.77 Million USD | 32.17% |
| 2007 Q4 | 3.77 Million USD | 0.56% |
| 2007 Q3 | 3.75 Million USD | 17.54% |
| 2007 Q2 | 3.19 Million USD | 3.41% |
| 2006 FY | 2.85 Million USD | 57.21% |
| 2006 Q1 | 2.36 Million USD | 30.34% |
| 2006 Q2 | 2.66 Million USD | 12.69% |
| 2006 Q3 | 3.61 Million USD | 35.41% |
| 2006 Q4 | 2.85 Million USD | -20.96% |
| 2005 Q4 | 1.81 Million USD | -17.26% |
| 2005 FY | 1.81 Million USD | -46.03% |
| 2005 Q1 | 2.95 Million USD | -12.05% |
| 2005 Q2 | 2.87 Million USD | -2.86% |
| 2005 Q3 | 2.19 Million USD | -23.66% |
| 2004 Q3 | 3.5 Million USD | 7.67% |
| 2004 Q2 | 3.25 Million USD | -9.03% |
| 2004 Q1 | 3.57 Million USD | 7.29% |
| 2004 Q4 | 3.36 Million USD | -3.97% |
| 2004 FY | 3.36 Million USD | 0.92% |
| 2003 FY | 3.33 Million USD | -7.67% |
| 2003 Q1 | 3.49 Million USD | -3.34% |
| 2003 Q3 | 3.41 Million USD | 11.41% |
| 2003 Q2 | 3.06 Million USD | -12.09% |
| 2003 Q4 | 3.33 Million USD | -2.47% |
| 2002 Q2 | 4.87 Million USD | -1.48% |
| 2002 FY | 3.61 Million USD | -26.97% |
| 2002 Q4 | 3.61 Million USD | -17.18% |
| 2002 Q3 | 4.36 Million USD | -10.48% |
| 2002 Q1 | 4.94 Million USD | -0.01% |
| 2001 Q3 | 4.21 Million USD | 15.73% |
| 2001 FY | 4.94 Million USD | 17.5% |
| 2001 Q1 | 3.77 Million USD | -10.23% |
| 2001 Q2 | 3.64 Million USD | -3.54% |
| 2001 Q4 | 4.94 Million USD | 17.25% |
| 2000 FY | 4.2 Million USD | -20.59% |
| 2000 Q2 | 5 Million USD | -5.66% |
| 2000 Q3 | 4.55 Million USD | -8.9% |
| 2000 Q4 | 4.2 Million USD | -7.6% |
| 2000 Q1 | 5.3 Million USD | 0.0% |
| 1999 Q1 | 5.1 Million USD | 21.43% |
| 1999 Q3 | 5.4 Million USD | 1.89% |
| 1999 Q4 | 5.3 Million USD | -1.85% |
| 1999 Q2 | 5.3 Million USD | 3.92% |
| 1999 FY | 5.3 Million USD | 26.19% |
| 1998 Q2 | 3.2 Million USD | 28.0% |
| 1998 Q3 | 3.4 Million USD | 6.25% |
| 1998 Q4 | 4.2 Million USD | 23.53% |
| 1998 FY | 4.2 Million USD | 50.0% |
| 1998 Q1 | 2.5 Million USD | -10.71% |
| 1997 Q2 | 2.7 Million USD | -3.57% |
| 1997 Q4 | 2.8 Million USD | 16.67% |
| 1997 FY | 2.8 Million USD | -6.67% |
| 1997 Q1 | 2.8 Million USD | -6.67% |
| 1997 Q3 | 2.4 Million USD | -11.11% |
| 1996 Q3 | 2.1 Million USD | 0.0% |
| 1996 FY | 3 Million USD | 36.36% |
| 1996 Q1 | 2.2 Million USD | 0.0% |
| 1996 Q2 | 2.1 Million USD | -4.55% |
| 1996 Q4 | 3 Million USD | 42.86% |
| 1995 Q1 | 2.3 Million USD | -4.17% |
| 1995 FY | 2.2 Million USD | -8.33% |
| 1995 Q4 | 2.2 Million USD | 0.0% |
| 1995 Q3 | 2.2 Million USD | -4.35% |
| 1995 Q2 | 2.3 Million USD | 0.0% |
| 1994 Q3 | 2.5 Million USD | 0.0% |
| 1994 Q1 | 2.1 Million USD | 61.54% |
| 1994 Q2 | 2.5 Million USD | 19.05% |
| 1994 Q4 | 2.4 Million USD | -4.0% |
| 1994 FY | 2.4 Million USD | 84.62% |
| 1993 FY | 1.3 Million USD | 1200.0% |
| 1993 Q3 | 800 Thousand USD | 100.0% |
| 1993 Q1 | 100 Thousand USD | 0.0% |
| 1993 Q2 | 400 Thousand USD | 300.0% |
| 1993 Q4 | 1.3 Million USD | 62.5% |
| 1992 Q4 | 100 Thousand USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 FY | 100 Thousand USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q3 | 100 Thousand USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 98.765% |
| Nemaura Medical Inc. | 20.03 Million USD | 66.611% |
| NeuroPace, Inc. | 72.39 Million USD | 90.762% |
| LENSAR, Inc. | 2.3 Million USD | -189.647% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | 8.958% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -319.307% |
| Apyx Medical Corporation | 38.5 Million USD | 82.629% |
| Cutera, Inc. | 431.91 Million USD | 98.452% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | 57.219% |
| BioSig Technologies, Inc. | 452 Thousand USD | -1379.635% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 82.948% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.602% |
| Axonics, Inc. | 27.61 Million USD | 75.783% |
| IRIDEX Corporation | 2.74 Million USD | -143.552% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 91.556% |
| TELA Bio, Inc. | 42.78 Million USD | 84.367% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -1712.453% |
| RxSight, Inc. | 3.01 Million USD | -122.044% |
| Align Technology, Inc. | 96.96 Million USD | 93.103% |
| INVO Bioscience, Inc. | 8.68 Million USD | 22.981% |
| electroCore, Inc. | 626 Thousand USD | -968.363% |
| Telesis Bio, Inc. | 34.38 Million USD | 80.547% |
| Viemed Healthcare, Inc. | 10.27 Million USD | 34.886% |
| Quipt Home Medical Corp. | 98.94 Million USD | 93.241% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 76.967% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -184.836% |
| Lucid Diagnostics Inc. | 15.25 Million USD | 56.159% |
| Modular Medical, Inc. | 1.19 Million USD | -462.013% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -2452.653% |
| Talis Biomedical Corporation | 19.66 Million USD | 65.996% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -389.945% |
| InMode Ltd. | 9.01 Million USD | 25.83% |
| Envoy Medical, Inc. | 404 Thousand USD | -1555.433% |
| Bruker Corporation | 1.37 Billion USD | 99.515% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -11633.247% |
| DexCom, Inc. | 2.59 Billion USD | 99.742% |
| Nexalin Technology, Inc. | 4463.00 USD | -149753.26% |
| PAVmed Inc | 48.72 Million USD | 86.274% |
| Viveve Medical, Inc. | 5.34 Million USD | -25.032% |
| Cerus Corporation | 95.99 Million USD | 93.033% |
| Movano Inc. | 252 Thousand USD | -2553.949% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 79.84% |
| Nexalin Technology, Inc. | 4463.00 USD | -149753.26% |
| IceCure Medical Ltd | 599 Thousand USD | -1016.519% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 98.391% |
| enVVeno Medical Corporation | 1.4 Million USD | -377.029% |
| 908 Devices Inc. | 5.94 Million USD | -12.497% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | 52.027% |
| Orthofix Medical Inc. | 134.19 Million USD | 95.016% |
| Surmodics, Inc. | 29.4 Million USD | 77.256% |
| Nuwellis, Inc. | 981 Thousand USD | -581.748% |
| Outset Medical, Inc. | 136.18 Million USD | 95.089% |
| Venus Concept Inc. | 79.69 Million USD | 91.608% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 94.848% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 90.487% |
| Nano-X Imaging Ltd. | 8.39 Million USD | 20.344% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -611.245% |
| Inogen, Inc. | 21.92 Million USD | 69.493% |
| IRadimed Corporation | 2.04 Million USD | -227.352% |
| MaxCyte, Inc. | 18.74 Million USD | 64.318% |
| Pulmonx Corporation | 41.42 Million USD | 83.855% |
| PAVmed Inc. | 48.72 Million USD | 86.274% |
| iCAD, Inc. | 461 Thousand USD | -1350.749% |
| OrthoPediatrics Corp. | 23.76 Million USD | 71.852% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -234.984% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -1259.365% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -3526.871% |
| SI-BONE, Inc. | 38.99 Million USD | 82.848% |
| Semler Scientific, Inc. | 70 Thousand USD | -9454.216% |
| Beyond Air, Inc. | 17.83 Million USD | 62.505% |
| FONAR Corporation | 41.67 Million USD | 83.952% |
| AxoGen, Inc. | 69.29 Million USD | 90.348% |
| Biotricity, Inc. | 23.87 Million USD | 71.992% |
| Cytosorbents Corporation | 18.31 Million USD | 63.48% |
| ZimVie Inc. | 521.92 Million USD | 98.719% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 86.724% |
| Inari Medical, Inc. | 32.04 Million USD | 79.131% |
| UFP Technologies, Inc. | 46.03 Million USD | 85.473% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -234.984% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -117.773% |
| Sight Sciences, Inc. | 35.41 Million USD | 81.115% |
| Insulet Corporation | 1.44 Billion USD | 99.538% |
| Profound Medical Corp. | 7.9 Million USD | 15.346% |
| Bioventus Inc. | 409.47 Million USD | 98.367% |
| InspireMD, Inc. | 1.59 Million USD | -319.307% |
| BrainsWay Ltd. | 471 Thousand USD | -1319.947% |
| BIOLASE, Inc. | 17.91 Million USD | 62.658% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -545.345% |
| Tenon Medical, Inc. | 1.17 Million USD | -470.158% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -567.46% |
| CVRx, Inc. | 30.61 Million USD | 78.153% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.709% |
| Sintx Technologies, Inc. | 4.24 Million USD | -57.549% |
| Acutus Medical, Inc. | 38.47 Million USD | 82.619% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -235.236% |
| NanoVibronix, Inc. | 5000.00 USD | -133659.02% |
| Quanterix Corporation | 41.46 Million USD | 83.87% |
| LivaNova PLC | 640.4 Million USD | 98.956% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -123.635% |
| Varex Imaging Corporation | 469.5 Million USD | 98.576% |
| Vivani Medical, Inc. | 20.69 Million USD | 67.685% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -184.836% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -754.144% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 99.284% |
| TransMedics Group, Inc. | 515.94 Million USD | 98.704% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -251.443% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -2676.512% |
| Spectral AI, Inc. | 1.28 Million USD | -418.848% |
| Hyperfine, Inc. | 185 Thousand USD | -3515.109% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 96.521% |
| Biomerica, Inc. | 785 Thousand USD | -751.968% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -1387.921% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -1707.042% |
| Silk Road Medical, Inc | 84.63 Million USD | 92.098% |